Predicted to enable double-stranded DNA binding activity and nucleosomal DNA binding activity. Predicted to be a structural constituent of chromatin. Predicted to be involved in chromosome condensation and negative regulation of DNA recombination. Predicted to act upstream of or within chromatin organization and negative regulation of transcription by RNA polymerase II. Predicted to be located in euchromatin. Predicted to be part of nucleosome. Predicted to be active in nucleus. Orthologous to human H1-3 (H1.3 linker histone, cluster member).
RGD Description
Predicted to enable double-stranded DNA binding activity and nucleosomal DNA binding activity. Predicted to be a structural constituent of chromatin. Predicted to be involved in chromosome condensation and negative regulation of DNA recombination. Predicted to act upstream of or within chromatin organization and negative regulation of transcription by RNA polymerase II. Predicted to be located in euchromatin. Predicted to be part of nucleosome. Predicted to be active in nucleus. Orthologous to human H1-3 (H1.3 linker histone, cluster member); INTERACTS WITH 17beta-estradiol; aconitine; bisphenol A.